ILCOR suggest the use of amiodarone or lidocaine in adults with shock refractory ventricular fibrillation/pulseless ventricular tachycardia
Amiodarone is an antiarrhythmic medication used to treat life-threatening ventricular arrhythmias, such as refractory ventricular fibrillation.
The recommended first intravenous dose of amiodarone for a patient with refractory ventricular fibrillation is 300 mg.
by I Kodama 2024 Cited by 435dose amiodarone therapy on patients with sustained ventricular tachycardia or ventricular fibrillation. refractory period prolongation by amiodarone
The recommended first intravenous dose of Amiodarone for a patient with refractory ventricular fibrillation is 300 mg (Option A). Amiodarone is an antiarrhythmic medication that is used to treat life-threatening ventricular arrhythmias such as refractory ventricular fibrillation.
The recommended first intravenous dose of amiodarone for a patient with refractory ventricular fibrillation is 300 mg. It is administered as a rapid infusion
ILCOR suggest the use of amiodarone or lidocaine in adults with shock refractory ventricular fibrillation/pulseless ventricular tachycardia (VF/
Ventricular fibrillation or pulseless ventricular tachycardia refractory to defibrillation (for cardiopulmonary resuscitation) for amiodarone hydrochloride.
The recommended first intravenous dose of amiodarone for a patient with refractory ventricular fibrillation is 300 mg.
Comments